1Given-Wilson R,Pope RM,Michell MJ,et al.The use of real-time orbital ultrasound in Graves' ophthalmopathy:a comparison with computed tomography.Br J Radiol,1989,62:705～709.
4Wiersinga WM,Prummel MF.An evidence-based approach to the treatment of Graves'ophthalmopathy.Edocrinol Metab Clin North Am,2000,29:297～319.
二级参考文献13
1Smolen JS,Kalden JR,Scott DI,et al.Efficacy and safety of leflunomide compared with placebo and sulphsalazine in active rheumatoid arthritis: a doubleblind, randomised, multicentre trial[].The Lancet.1999
2Fox RI.Mechanism of action of leflunomide in rheumatoid arthritis[].Journal of Rheumatology The.1998
3Ruckermann K,Fairbanks LD,Carrey LA,et al.Leflunomide inhibits pyrimidine denovo synthesis in mitogen-stimulated T lymphocytes from healthy humans[].Journal of Biological Chemistry.1998
8KahalyG,PitzS,MullerForellW ,etal.RandomizedtrialofintravenousimmunoglobulinsversusprednisoloneinGraves′ophthalmopathy[].Clinical and Experimental Immunology.1996
5Bartalena L,Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives [J]. Endocr Rev,2000,21(2):168-199.
6Kung AW,Yau CC,Cheng AC. The action of methimazole and L-thyroxine in radioiodine therapy: a prospective study on the incidence of hypothyroidism[J]. Thyroid, 1995,5 (1) : 7-12.
7Komorowski J, Jankiewicz-Wika J, Siejka A. Monoclonal anti- TNFalpha antibody (infliximab) in the treatment of patient with thyroid associated ophthalmopathy[J]. Klin Oczna,2007, 109(10/12) :457-460.
